Cargando…

The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease

Parkinson’s disease is the second most common neurodegenerative disorder; it affects 1% of the population over the age of 65. The number of people with Parkinson’s disease is set to rapidly increase due to changing demographics and there is an unmet clinical need for disease-modifying therapies. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goulding, Susan R., Sullivan, Aideen M., O'Keeffe, Gerard W., Collins, Louise M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059567/ https://www.ncbi.nlm.nih.gov/pubmed/31997802 http://dx.doi.org/10.4103/1673-5374.274327

Ejemplares similares

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease
por: Goulding, Susan R., et al.
Publicado: (2021)

Neurotrophic factor therapy for Parkinson's disease: past, present and future
por: Sullivan, Aideen M., et al.
Publicado: (2016)

Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease
por: O'Keeffe, Gerard W., et al.
Publicado: (2017)

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2014)

STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5
por: Anantha, Jayanth, et al.
Publicado: (2020)

Protocol for evaluation of neurotrophic strategies in Parkinson’s disease-related dopaminergic and sympathetic neurons in vitro
por: Hegarty, Shane V., et al.
Publicado: (2016)

Association of distinct type 1 bone morphogenetic protein receptors with different molecular pathways and survival outcomes in neuroblastoma
por: Alshangiti, Amnah M., et al.
Publicado: (2020)

The class II histone deacetylases as therapeutic targets for Parkinson’s disease
por: Mazzocchi, Martina, et al.
Publicado: (2020)

Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling
por: Mazzocchi, Martina, et al.
Publicado: (2019)

The Epigenome as a therapeutic target for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2016)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

Diet quality, sleep and quality of life in Parkinson’s disease: a cross-sectional study
por: Dunk, Danielle, et al.
Publicado: (2022)

NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease
por: Anantha, Jayanth, et al.
Publicado: (2021)

Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease
por: Hegarty, Shane V., et al.
Publicado: (2018)

Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease
por: Costello, Daniel J, et al.
Publicado: (2012)

Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease
por: Collins, Louise M, et al.
Publicado: (2014)

Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease
por: Hegarty, Shane V., et al.
Publicado: (2020)

Gene Co-expression Analysis of the Human Substantia Nigra Identifies ZNHIT1 as an SNCA Co-expressed Gene that Protects Against α-Synuclein-Induced Impairments in Neurite Growth and Mitochondrial Dysfunction in SH-SY5Y Cells
por: McCarthy, Erin, et al.
Publicado: (2022)

The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells
por: Alshangiti, Amnah M., et al.
Publicado: (2019)

Role of RGM coreceptors in bone morphogenetic protein signaling
por: Halbrooks, Peter J, et al.
Publicado: (2007)

4-Hydroxychalcone Induces Cell Death via Oxidative Stress in MYCN-Amplified Human Neuroblastoma Cells
por: Alshangiti, Amnah M., et al.
Publicado: (2019)

Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation
por: Hegarty, Shane V., et al.
Publicado: (2017)

Bone Morphogenetic Proteins: Periodontal Regeneration
por: Rao, Subramaniam M, et al.
Publicado: (2013)

The Classic: Bone Morphogenetic Protein
por: Urist, Marshall R., et al.
Publicado: (2009)

Bone morphogenetic protein-4 and bone morphogenetic protein receptors expressions in the adult rat eye
por: Maruyama-Koide, Yuka, et al.
Publicado: (2017)

Nuclear variants of bone morphogenetic proteins
por: Felin, Jenny E, et al.
Publicado: (2010)

Bone morphogenetic protein guts it out
por: Leslie, Mitch
Publicado: (2013)

Bone morphogenetic proteins: The anomalous molecules
por: Jain, Aena Pundir, et al.
Publicado: (2013)

Bone Morphogenetic Proteins and Diabetic Retinopathy
por: Elmasry, Khaled, et al.
Publicado: (2021)

Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor
por: Miller, Kathryn M., et al.
Publicado: (2021)

Bone Morphogenetic Proteins for Nucleus Pulposus Regeneration
por: Krouwels, Anita, et al.
Publicado: (2020)

Bone morphogenetic protein-2: a potential regulator in scleral remodeling
por: Hu, Jianmin, et al.
Publicado: (2008)

Beyond osteogenesis: an in vitro comparison of the potentials of six bone morphogenetic proteins
por: Rivera, Jessica C., et al.
Publicado: (2013)

Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma
por: Xi, Guifa, et al.
Publicado: (2017)

Bone Morphogenetic Protein-2 in Development and Bone Homeostasis
por: Halloran, Daniel, et al.
Publicado: (2020)

Bone morphogenetic proteins: Signaling periodontal bone regeneration and repair
por: Anusuya, G. Sai, et al.
Publicado: (2016)

Regulation of Bone Morphogenetic Protein Signaling by ADP-ribosylation
por: Watanabe, Yukihide, et al.
Publicado: (2016)

Diversity and robustness of bone morphogenetic protein pattern formation
por: Madamanchi, Aasakiran, et al.
Publicado: (2021)

Bone morphogenetic proteins in destructive and remodeling arthritis
por: Lories, Rik JU, et al.
Publicado: (2007)

Bone Morphogenetic Protein Signaling: Implications in Urology
por: Jeong, Jeongyun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_giufjlcvrk6fmrhtjabo8ck1cg